http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28229810

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Review
endingPage 204
issn 1368-7646
issueIdentifier 6
pageRange 196-204
publicationName Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
startingPage 196
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_22eea0c588aa956d15373bef9ee7922c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5981c1c1b02aceea934db438b33290cf
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c9fa29e94c0362eff390527a39e86f91
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6360dac06a454b27fb7b82a2c0005558
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cf777824cac46b2e40f9d0e836e68e23
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_834da1aca71a1fc75a2dc75cb0ef521d
bibliographicCitation Gadgeel SM, Cote ML, Schwartz AG, Matherly LH, Wozniak A, Bepler G. Parameters for individualizing systemic therapy in non-small cell lung cancer. Drug Resistance Updates. 2010 Dec;13(6):196–204. doi: 10.1016/j.drup.2010.10.001.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28f3bde56706bf433f85c7471a838a6d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_082095037526ad53ccac603d70127d47
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb06615f6842e5d14bb8784c3a6c47c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_092fc7e1b07ab4864703e168c51299ef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d4c83402fb3a8a01e8c9c3dcfc50f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7f382de3510260f00c3f0f76efc9406
date 201012
identifier https://pubmed.ncbi.nlm.nih.gov/PMC3865930
https://doi.org/10.1016/j.drup.2010.10.001
https://pubmed.ncbi.nlm.nih.gov/21051275
isPartOf https://portal.issn.org/resource/ISSN/1368-7646
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/25462
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Parameters for individualizing systemic therapy in non-small cell lung cancer
discusses http://id.nlm.nih.gov/mesh/M0023752
http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008175Q000188
http://id.nlm.nih.gov/mesh/D057285Q000379
http://id.nlm.nih.gov/mesh/D003663
http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D008175Q000378
http://id.nlm.nih.gov/mesh/D008175Q000235
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D002289Q000378
http://id.nlm.nih.gov/mesh/D002289Q000235
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015415
http://id.nlm.nih.gov/mesh/D000970Q000008
http://id.nlm.nih.gov/mesh/D057285Q000639
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243164928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 61.